Journal of Clinical and Cellular Immunology
Open Access

Human Immuno Deficiency Virus (HIV) Immunology: Its Mechanisms, Pathogenesis and Immune Invasions

Jennifer Bohl^{* *}Correspondence: Jennifer Bohl, Department of Immunology, University of Bucharest, Bucharest, Romania, Email:

Author info »

Description

Human Immuno Deficiency Virus/ Acquired Immuno Deficiency Syndrome (HIV/AIDS) remains one of the most pressing global health challenges of our time. Despite significant progress in treatment and prevention, HIV continues to affect millions worldwide. Understanding the immunology of HIV, the virus that causes AIDS, is crucial for developing effective therapies and vaccines. The study discuss about the intricate interplay between HIV and the human immune system, its complex mechanisms underlying HIV pathogenesis and immune evasion strategies.

HIV structure and replication

HIV belongs to the family of retroviruses and has a unique structure consisting of an Envelope glycoprotein (Env), a lipid bilayer and a protein capsid enclosing the viral RNA genome. Upon entry into the host cell, typically CD⁴⁺ T lymphocytes and macrophages, HIV undergoes a series of steps to establish infection. The viral RNA is reverse transcribed into Deoxy Ribo Nuclic Acid (DNA) by the enzyme reverse transcriptase and the resulting viral DNA is integrated into the host cell genome by the viral integrase enzyme. This integrated DNA, known as provirus, serves as a template for viral RNA and protein production, ultimately leading to the assembly and release of new virions.

Host immune response to HIV

The human immune system mounts a multifaceted response to HIV infection involving both innate and adaptive immune mechanisms. Upon encountering HIV, innate immune cells such as dendritic cells and macrophages recognize viral components through Pattern Recognition Receptors (PRRs) and initiate antiviral responses, including the production of cytokines and chemokines. Additionally, Natural Killer (NK) cells play a critical role in eliminating HIV-infected cells through cytotoxic mechanisms [1].

The adaptive immune response to HIV primarily involves CD⁴⁺ and CD⁸⁺ Tlymphocytes. CD⁴⁺ T cells are the primary targets of of HIV infection, and their depletion is a hallmark of disease progression to AIDS. CD⁸⁺ T cells, also known as Cytotoxic T Lymphocytes (CTLs), recognize and eliminate HIV-infected cells by recognizing viral antigens presented on the surface of infected cells. However, HIV has evolved various strategies to evade immune detection, including mutation of viral epitopes, downregulation of Major Histocompatibility Complex (MHC) molecules and inhibition of T cell function [2].

Challenges in HIV vaccine development

Despite decades of research, the development of an effective HIV vaccine remains elusive. The high mutation rate of HIV, coupled with its ability to establish latent reservoirs and evade immune detection, poses significant challenges to vaccine design. Additionally, the diversity of HIV strains circulating globally necessitates the development of a vaccine that provides broad and durable protection against multiple viral variants. Recent advances in vaccine technologies, including viral vector-based vaccines and mosaic antigens, offer assurancing avenues for overcoming these challenges [3].

Therapeutic strategies for HIV

Antiretroviral Therapy (ART) has revolutionized the management of HIV infection by suppressing viral replication and restoring immune function. ART typically consists of a combination of drugs targeting different stages of the viral lifecycle, including reverse transcriptase inhibitors, protease inhibitors and integrase inhibitors. However, ART does not cure HIV infection and long-term adherence to therapy is essential to prevent viral rebound and disease progression. Novel therapeutic approaches, such as latency-reversing agents and gene editing technologies, are being explored as potential strategies to achieve viral eradication or functional cure [4].

Conclusion

The immunology of HIV is a complex and dynamic field that continues to yield insights into the mechanisms of viral pathogenesis and immune evasion. Understanding the interplay between HIV and the human immune system is essential for developing effective strategies to prevent and treat HIV infection. While significant progress has been made, continued research efforts are needed to overcome the remaining challenges and ultimately achieve the goal of ending the HIV/ AIDS pandemic.

References

1. D'Souza MP, Rele S, Haynes BF, Hu DJ, Kaplan DL, Mamaghani S, et al. Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology. Vaccine. 2020;38(2):187-193.

   [Crossref] [Google Scholar] [PubMed]

2. Kulpa DA, Silvestri G. Introduction to the Special Issue: Immunology of HIV and SIV infection. Semin Immunol. 2021;51:101484. 

   [Crossref] [Google Scholar] [PubMed]

3. Doria-Rose NA, Mascola JR. HIV immunology goes out on a limb. Immunity. 2016;44(5):1088-1090.

   [Crossref] [Google Scholar] [PubMed]

4. Rudy BJ, Crowley-Nowick PA, Douglas SD. Immunology and the REACH study: HIV immunology and preliminary findings. J Adolesc Health. 2001;29(3):39-48.

   [Crossref] [Google Scholar] [PubMed]